-
1
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
-
(2010)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack Jr., C.R.1
Knopman, D.S.2
Jagust, W.J.3
-
2
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B
-
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004;55:306-319.
-
(2004)
Ann Neurol
, vol.55
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
-
3
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
-
4
-
-
84867528523
-
Indicators of amyloid burden in a population-based study of cognitively normal elderly
-
Mielke MM, Wiste HJ, Weigand SD, et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology 2012;79:1570-1577.
-
(2012)
Neurology
, vol.79
, pp. 1570-1577
-
-
Mielke, M.M.1
Wiste, H.J.2
Weigand, S.D.3
-
5
-
-
77649314191
-
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
-
Morris JC, Roe CM, Xiong C, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010;67:122-131.
-
(2010)
Ann Neurol
, vol.67
, pp. 122-131
-
-
Morris, J.C.1
Roe, C.M.2
Xiong, C.3
-
6
-
-
77949408552
-
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]
-
Resnick SM, Sojkova J, Zhou Y, et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 2010;74:807-815.
-
(2010)
PiB. Neurology
, vol.74
, pp. 807-815
-
-
Resnick, S.M.1
Sojkova, J.2
Zhou, Y.3
-
7
-
-
73549106106
-
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition
-
Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition. Arch Neurol 2009;66:1476-1481.
-
(2009)
Arch Neurol
, vol.66
, pp. 1476-1481
-
-
Storandt, M.1
Mintun, M.A.2
Head, D.3
Morris, J.C.4
-
8
-
-
67650875899
-
Amyloid deposition is associated with impaired default network function in older persons without dementia
-
Sperling RA, Laviolette PS, O'Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009;63: 178-188.
-
(2009)
Neuron
, vol.63
, pp. 178-188
-
-
Sperling, R.A.1
Laviolette, P.S.2
O'Keefe, K.3
-
9
-
-
70349876480
-
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden
-
Hedden T, Van Dijk KR, Becker JA, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 2009;29:12686-12694.
-
(2009)
J Neurosci
, vol.29
, pp. 12686-12694
-
-
Hedden, T.1
Van Dijk, K.R.2
Becker, J.A.3
|